4//SEC Filing
Chaubey Alka 4
Accession 0001209191-23-010919
CIK 0001411690other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:21 PM ET
Size
7.8 KB
Accession
0001209191-23-010919
Insider Transaction Report
Form 4
Chaubey Alka
Chief Medical Officer
Transactions
- Award
Common Stock
2023-02-15+120,000→ 124,794 total - Award
Stock Option (Right to Buy)
2023-02-15+560,000→ 560,000 totalExercise: $1.63Exp: 2033-02-14→ Common Stock (560,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
- [F2]Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022.
- [F3]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.
Documents
Issuer
Bionano Genomics, Inc.
CIK 0001411690
Entity typeother
Related Parties
1- filerCIK 0001821605
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 7:21 PM ET
- Size
- 7.8 KB